Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - January 22, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Veterans
Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - January 22, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Percipio Health raises $20M and unveils AI-powered Population Health Monitoring platform
The platform collects and analyzes multiple health signals via smartphone, without medical monitoring devices, to reach broader populations at lower...
Scienture Holdings, Inc. Announces Dr. Narasimhan Mani’s Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics
TAMPA, FL, Jan. 21, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a Specialty Pharma company with a novel...
Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain
Event will feature insights on LX9211, Lexicon’s novel, investigational, non-opioid treatment, as well as expert panel and Q&A session on...
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Homecare Homebase Wraps 2024 with Growth, Product Innovation and Industry Leadership
From improving patient care quality to driving customer success, HCHB continues to lead the home-based care industry with enhanced technology,...
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates
Awards in favour of Quantum BioPharma Total Approximately $3 Million TORONTO, ON / ACCESS Newswire / January 17, 2025 /...
StaffDNA®; LiquidAgents CEO Sheldon Arora Named to the 2025 SIA Staffing 100 North America List
PLANO, Texas, Jan. 16, 2025 /PRNewswire/ -- Sheldon Arora, CEO of StaffDNA® and LiquidAgents Healthcare, has been named one of the...
LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals
DSS Advances OR Efficiency and Patient Access to Surgery Across 85% of VA Medical Centers With LiveData Software DeploymentCAMBRIDGE, Mass.--(BUSINESS...
Avicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin Pharma
Collaboration aims to facilitate research and medical affairs initiatives related to medical cannabis in CanadaTORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE)...
The Joint Corp. Reports 2024 Operating Metrics
- Adjustments Performed in 2024 Grows 9%, Compared to 2023 -- Receives Letters of Intent for the majority of the...
Metagenomi Announces New Appointment to its Board of Directors
EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing...
Apollo Neuro Partners with GOVX to Better Serve Those Who Serve Us
PITTSBURGH, Jan. 14, 2025 /PRNewswire/ -- Today, Apollo Neuroscience is proud and honored to announce our latest partnership with GOVX, an e-commerce...
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM
Quantum BioPharma Ltd. Dual Lists on Upstream's Global Securities Trading App TORONTO, ON / ACCESSWIRE / January 14, 2025 /...
Ex-Deep Genomics, Moderna Execs Get Backing Led by Gradient to Develop Next-Generation mRNA Therapeutics with AI
SAN FRANCISCO, Jan. 13, 2025 /PRNewswire/ -- Kerna Laboratories Inc, a San Francisco-based AI biotech startup, emerged from stealth with the...
RESTEM Provides Corporate Update and Announces Key Business Objectives for 2025
MIAMI, Jan. 10, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed...
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets...
Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations in the Journal of Vascular Anomalies
Publication reports 100% of participants were either “Much Improved” or “Very Much Improved” as rated by the Clinician Global Impression...
UnisLink Appoints Julie Klapstein and Christine Schuster to Board of Directors
New board members provide depth in technology-enabled healthcare services, revenue cycle management, and clinical practice PHOENIX, Jan. 9, 2025 /PRNewswire/...